Healthcare Global Enterprises Limited has informed the Exchange regarding Outcome of Board Meeting held on February 17, 2026 with respect to the approval received from the board of directors of the Company ( Board ), for the issuance of fully paid-up equity shares of the Company of face value of ₹10 each (the Equity Shares ) for an amount not exceeding ₹ 42,500 Lakhs (Rupees Forty Two Thousand and Five Hundred Lakhs) by way of a rights issue to the eligible equity shareholders of the Company as on the record date (to be determined and notified subsequently), in accordance with applicable laws, including the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended, subject to such regulatory and statutory approvals, as may be required under the applicable laws.
HCG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Healthcare Global Enterprises Limited's board, at its meeting on February 17, 2026, approved a rights issue of fully paid-up equity shares with a face value of ₹10 each for an amount not exceeding ₹42,500 Lakhs (approximately ₹425 Crores). The shares will be offered to eligible equity shareholders as on a record date, which will be notified later. The issue will be carried out in accordance with the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 and is subject to necessary regulatory and statutory approvals. The company has not yet disclosed the specific purpose or use of funds, the issue price, or the rights entitlement ratio.
Existing shareholders will get the first opportunity to subscribe to the rights issue and may need to arrange additional capital to maintain their stake. The stock could see short-term dilution pressure until the issue price and record date are announced.